Literature DB >> 1928562

Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection.

Y Gutierrez1, G H Salinas, G Palma, L B Valderrama, C V Santrich, N G Saravia.   

Abstract

Skin biopsies from 221 parasitologically confirmed cases of tegumentary leishmaniasis caused by Leishmania braziliensis spp. were evaluated with respect to histopathology, the qualitative and quantitative nature of the cellular infiltrate, and the presence of Leishmania amastigotes. These variables were cross correlated with the Leishmania-specific immune response, clinical presentation, and response to treatment. Physical evidence of prior leishmanial lesions was associated with the absence of amastigotes (P less than or equal to 0.001) and the presence of giant (P = 0.03) and epitheloid cells (P = 0.03) in the biopsy of the active lesion. The presence of amastigotes was inversely related to the duration of the lesion (P less than or equal to 0.001) and the presence of eosinophils (P less than or equal to 0.01), whereas the presence of adenopathy (P = 0.01), necrosis (P = 0.001), histiocytes (P = 0.001), and increased serum antibody titer (P = 0.02) were directly associated with the presence of amastigotes. The lymphocyte transformation response was correlated with the presence of granulomas (P = 0.001), but showed no correlation with cutaneous delayed type hypersensitivity. The presence of epithelioid (P = 0.04) and giant cells (P = 0.03) was associated with less drug being required to achieve healing. In contrast, necrosis was associated with a greater amount of drug to achieve healing (P = 0.05). The observed correlations between tissue responses and immune and clinical parameters provide further evidence for the role of antibody and other soluble mediators of the cellular immune response in the evolution of disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928562     DOI: 10.4269/ajtmh.1991.45.281

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Evaluation of PCR as a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. in domestic dogs (Canis familiaris).

Authors:  Richard Reithinger; Juan Canales Espinoza; Orin Courtenay; Clive R Davies
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon- and interleukin-5-producing CD4(+) antigen-specific T cells.

Authors:  C Mary; V Auriault; B Faugère; A J Dessein
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.

Authors:  Mariana C Duarte; Daniel C Pimenta; Daniel Menezes-Souza; Rubens D M Magalhães; João L C P Diniz; Lourena E Costa; Miguel A Chávez-Fumagalli; Paula S Lage; Daniela C Bartholomeu; Maria Julia M Alves; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Denise U Gonçalves; Manoel O C Rocha; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

4.  Genetic variant strains of Leishmania (Viannia) braziliensis exhibit distinct biological behaviors.

Authors:  Felipe Dutra Rêgo; Ana Cristina Vianna Mariano da Rocha Lima; Agnes Antônia Sampaio Pereira; Patrícia Flávia Quaresma; Marcelo Antônio Pascoal-Xavier; Jeffrey Jon Shaw; Célia Maria Ferreira Gontijo
Journal:  Parasitol Res       Date:  2018-07-18       Impact factor: 2.289

5.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

6.  Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.

Authors:  C R Davies; E A Llanos-Cuentas; S D Pyke; C Dye
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

7.  Leishmania (Viannia) panamensis-induced cutaneous leishmaniasis in Balb/c mice: pathology.

Authors:  J I Rojas; E Tani; A Orn; C Sánchez; H Goto
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

Review 8.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters.

Authors:  Marlene Jara; Vanessa Adaui; Braulio M Valencia; Dalila Martinez; Milena Alba; Carlos Castrillon; Maria Cruz; Israel Cruz; Gert Van der Auwera; Alejandro Llanos-Cuentas; Jean-Claude Dujardin; Jorge Arevalo
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

10.  Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic.

Authors:  D Otranto; P Paradies; D de Caprariis; D Stanneck; G Testini; F Grimm; P Deplazes; G Capelli
Journal:  Clin Vaccine Immunol       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.